オプションチェーンは、Sight Sciencesの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Sight Sciencesの市場センチメントを評価します。.

Sight Sciences (NASDAQ:SGHT) 株価情報, オプションチェーン

Sight Sciences

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Sight Sciences Inc

Needham analyst Laura Martin maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Buy and raises the price target from $135 to $145.

News

Price Target

Analyst Ratings

RDDT

Needham Maintains Buy on Reddit, Raises Price Target to $145

Stifel analyst Stephen Gengaro maintains Cactus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHD#NYSE">WHD</a>) with a Buy and lowers the price target from $61 to $57.

Stifel Maintains Buy on Cactus, Lowers Price Target to $57

Stifel analyst David Grossman maintains American Well (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMWL#NYSE">AMWL</a>) with a Hold and lowers the price target from $10 to $8.

AMWL

Stifel Maintains Hold on American Well, Lowers Price Target to $8

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) with a Buy and raises the price target from $1.5 to $7.

XFOR

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $7

Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia
Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques
IRVINE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences&#xAE; (NASDAQ:<a href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>), the premier physician-led weight loss and metabolic health solutions company, today announced it will present pre-clinical data on its proprietary Diabetes Neuromodulation device in a poster presentation at the 12th Annual Minnesota Neuromodulation Symposium, being held in Minneapolis.

RSLS

ReShape Lifesciences To Present Pre-Clinical Data On Proprietary Diabetes Neuromodulation Device At 12Th Annual Minnesota Neuromodulation Symposium

Stifel analyst Mark Kelley maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and lowers the price target from $248 to $245.

AMZN

Stifel Maintains Buy on Amazon.com, Lowers Price Target to $245

<ul>
<li>Company Aims to Exceed 1,000 Advertisers by Mid-Q2 and 5,000 Advertisers by the End of 2025</li>
<li>Thumzup's Plans Further Accelerate Growth and Market Penetration of its Innovative AdTech Platform</li>
</ul>
LOS ANGELES, May 2, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4418767-1&amp;h=2562076278&amp;u=https%3A%2F%2Fwww.thumzupmedia.com%2F&amp;a=Thumzup+Media+Corporation">Thumzup Media Corporation</a> ("Thumzup" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>), an emerging leader in social media branding and programmatic marketing solutions, is excited to announce it has surpassed 900 advertisers, a CAGR (Compound Annual Growth Rate) of 220%, marking a significant milestone in the Company's rapid expansion within the digital advertising space. Thumzup's growth trajectory remains strong, and the Company expects to reach 1,000 advertisers by mid-Q2 and 5,000 advertisers by the end of 2025.

TZUP

Thumzup Media Surpasses 900 Advertisers, CAGR Of 220%; Expects To Reach 1,000 Advertisers By Mid-Q2 And 5,000 Advertisers By 2025 End

Secure Energy Services (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SES#TSX">SES</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.26 by 38.46 percent. This is a 89.12 percent decrease over earnings of $1.47 per share from the same period last year. The company reported quarterly sales of $371.00 million which beat the analyst consensus estimate of $351.00 million by 5.70 percent. This is a 3.06 percent increase over sales of $360.00 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

TSX:SES

Secure Energy Services Q1 EPS $0.16 Misses $0.26 Estimate, Sales $371.00M Beat $351.00M Estimate

Stifel analyst Frank Galanti upgrades FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) from Hold to Buy and maintains the price target from $123 to $123.

Upgrades

FTAI

Stifel Upgrades FTAI Aviation to Buy, Maintains Price Target to $123

Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) shares are trading higher after the company&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45161321/exxonmobil-announces-first-quarter-2025-results" rel="noreferrer noopener">reported&nbsp;first-quarter&nbsp;results</a>.&nbsp;
Total revenues and other income&nbsp;stood at&nbsp;$83.1 billion, missing the consensus of&nbsp;$86.1 billion.
ExxonMobil's total output held steady at 4.55 million barrels of oil equivalent per day in Q1.
Also Read: <a target="_blank" href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44949075/from-oil-rigs-to-runways-exxon-mobil-boeing-get-the-leveraged-trading-treatment" rel="noreferrer noopener">From Oil Rigs To Runways: Exxon Mobil, Boeing Get The Leveraged Trading Treatment</a>
Adjusted earnings dropped to $7.71 billion from $8.22 billion in Q4 2024, weighed down by weaker refining margins and lower crude prices.
Adjusted EPS stood at&nbsp;$1.76,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">beating the consensus of&nbsp;$1.70</a>.
Operating cash flow from operating activities stood at $13.0 billion and free cash flow came in at $8.8 billion in the quarter.
Exxon's&nbsp;capital expenditures stood at&nbsp;$5.9 billion in the&nbsp;quarter, including $5.9 billion of additions to property, plant, and equipment.
The company achieved a cumulative structural cost savings of&nbsp;$12.7&nbsp;billion&nbsp;versus 2019, including savings of&nbsp;$0.6&nbsp;billion&nbsp;in the quarter.
The company expects to deliver cumulative savings of&nbsp;$18 billion&nbsp;through <a target="_blank" href="https://www.benzinga.com//node/43389620" rel="noreferrer noopener">the end of 2030 versus 2019</a>.
Dividend &amp; Repurchase: Exxon expects a&nbsp;second-quarter dividend per share of&nbsp;$0.99, payable on June 10, to shareholders of record as of&nbsp;May 15, 2025.
The company's shareholder distributions totaled&nbsp;$9.1&nbsp;billion&nbsp;in the quarter, comprising&nbsp;$4.3&nbsp;billion&nbsp;in dividends and&nbsp;$4.8&nbsp;billion in share repurchases.
As announced earlier, ExxonMobil plans to expand its annual&nbsp;$20 billion&nbsp;share repurchase program through 2026.
Darren Woods, chairman and chief executive officer, said, "This year, we're starting up 10 advantaged projects that are expected to generate more than $3 billion of earnings in 2026 at constant prices and margins.&nbsp;Continuously leveraging our competitive advantage is enabling the company to excel in the current market environment and deliver on our plans through 2030 and far into the future."
Investors can gain exposure to XOM via EA Series Trust Strive U.S. Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRLL#NYSE">DRLL</a>) and&nbsp;Fidelity MSCI Energy Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENY#NYSE">FENY</a>).
Price Action: XOM shares are up&nbsp;1.22% at $107.07 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/buybacks/25/05/45164086/chevron-q1-profit-drops-on-higher-costs-weak-international-margins" target="_blank" rel="noreferrer noopener">Chevron Q1 Profit Drops On Higher Costs, Weak International Margins</a></li>
</ul>
Photo: Ken Wolter/Shutterstock

Equities

Large Cap

Guidance

Movers

DRLL

FENY

Exxon Mobil Q1: Steady Production, Focus On Cost Cuts And Stock Buyback

The U.S. labor market showed signs of strength in April, with hiring momentum topping estimates despite the impact of <a href="https://www.benzinga.com/topic/tariffs">trade tariffs across industries.</a>
Nonfarm payrolls increased by 177,000 last month, slightly down from a downwardly revised 185,000 in March, according to data released Friday by the Bureau of Labor Statistics. 
The outcome surpassed both economist forecasts for a 130,000 gain and betting markets – tracked by CFTC-regulated platform Kalshi – which had priced in a 90,000 increase.
In April, employment continued to rise across several sectors, including health care, transportation and warehousing, financial activities, and social assistance, while federal government jobs declined.
The health care sector added 51,000 jobs—closely in line with its 12-month average of 52,000. Notable increases were seen in hospitals, up 22,000, and ambulatory health care services, up 21,000.
Transportation and warehousing employment rose by 29,000, rebounding from a modest gain of 3,000 in March. Within the sector, job growth was concentrated in warehousing and storage, up 10,000, couriers and messengers, up 8,000, and air transportation, up 3,000. 
Federal government employment declined by 9,000, reflecting rising layoffs amid reforms led by Elon Musk's Department of Government Efficiency (DOGE).
The unemployment rate remained unchanged at 4.2%, as expected. 
Wage growth lost some momentum. Average hourly earnings rose 0.2% on the month, down from both the prior and expected 0.3%. On an annual basis, wages were up 3.8%, steady from March but slightly below the forecasted 3.9%.
Ahead of the April jobs report, money markets had priced in a 58% probability of a 25-basis-point rate cut at the Federal Reserve's June meeting, according to CME FedWatch.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Indicator</th>
<th>April 2025</th>
<th>March 2025 </th>
<th>Forecast</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nonfarm Payrolls</td>
<td>177,000</td>
<td>185,000 (downwardly revised from )</td>
<td>130,000</td>
</tr>
<tr>
<td>Unemployment Rate</td>
<td>4.2%</td>
<td>4.2%</td>
<td>4.2%</td>
</tr>
<tr>
<td>Avg. Hourly Earnings (MoM)</td>
<td>+0.2%</td>
<td>+0.3%</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Avg. Hourly Earnings (YoY)</td>
<td>+3.8%</td>
<td>+3.8%</td>
<td>+3.9%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">Market Reactions </h3>
The stronger-than-expected jobs data pushed the U.S. dollar and Treasury yields higher and boosted gains across major equity indices.
The U.S. Dollar Index, as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), trimmed session losses, down 0.2% by 8:35 a.m. ET. 
Treasury yields also rose, with the 2-year yield—often seen as a proxy for near-term rate expectations—rising 3 basis points to 3.74%.
S&amp;P 500 futures were up 0.7%, while tech stocks rose 0.8%. On Thursday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) closed 0.7% higher, marking its eighth consecutive session of gains.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45154011/gold-leaves-sp-500-in-the-dust-with-biggest-outperformance-in-14-years">Gold Leaves S&amp;P 500 In The Dust With Biggest Outperformance In 14 Years</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Econ #s

Economics

PowerShares DB US Dollar Index Bullish Fund

US Adds 177,000 Jobs In April, Topping Forecasts As Economy Navigates Tariff Impact

The Board of Directors of&nbsp;MSA Safety Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSA#NYSE">MSA</a>) today approved the company's 55th consecutive annual dividend increase, raising the quarterly dividend from $0.51 per common share to $0.53 per common share. &nbsp;The change reflects a 4% increase in the quarterly dividend and a 5% increase in 2025 dividends per common share compared to 2024. The dividend is payable on June 10, 2025, to shareholders of record on May 15, 2025.
The Board of Directors also declared a dividend of $0.5625 per share on preferred stock, payable June 1, 2025, to shareholders of record on May 15, 2025.
 &nbsp;

Dividends

MSA Safety Hikes Quarterly Dividend By 4% From $0.51 To $0.53 Per Share

Aegis Brands (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AEG#TSX">AEG</a>) reported $4.16 million in sales this quarter. This is a 8.29 percent decrease over sales of $4.54 million the same period last year.

TSX:AEG

Aegis Brands Q1 Sales $4.16M Down From $4.54M YoY

In a strategic move to stimulate domestic consumption, China is reportedly turning to the K-pop industry amid its ongoing&nbsp;trade war with the United&nbsp;States and a weakening domestic market.
What Happened:  China is set to host K-pop group Epex for a concert in Fuzhou, Fujian province, on May 31. This event marks the first performance by an all-Korean idol group in mainland China since 2016. Additionally, South Korea&#8217;s longest-running K-pop event—the Annual Dream concert- is set to take place on September 26 in China&#8217;s Hainan province, <a href="https://www.cnbc.com/2025/05/02/china-looks-set-to-turn-to-k-pop-sector-as-us-tariffs-bite.html?ref=biztoc.com">reported </a>CNBC.
These developments suggest a possible relaxation of China&#8217;s unofficial ban on K-pop acts, a shift that CGS International Securities Hong Kong research analyst Oh Jiwoo refers to as a &#8220;structural turning point&#8221; for the industry.
In February, CGS stated China&#8217;s concert market, which expanded by 189% from $2.9 billion in 2019 to $8 billion in 2024, could see a significant boost in 2025 if the country lifts the unofficial ban on South Korean artists.
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/05/45159157/mcdonalds-ceo-the-us-economy-is-dividedlow-income-traffic-down-10-while-rich-diners-continue-to-spend" target="_blank" rel="noreferrer noopener">McDonald&#8217;s CEO: &#8216;The US Economy Is Divided&#8217; As Wealthy Customers Keep Coming While Regular Families Cut Back</a>
Why It Matters:&nbsp;Recently, China&#8217;s Ministry of Culture and Tourism released a notice encouraging cultural events, such as concerts and music festivals, as per CNBC. The K-pop sector, unaffected by cross-border tariffs, is viewed as a strategic initiative to boost discretionary spending in tourism, hospitality, and local commerce.
According to analysts, China&#8217;s softened approach to K-pop also serves a diplomatic purpose, aiming to rebuild relationships with neighboring countries, such as South Korea, amid trade uncertainties. This shift may help revive K-pop&#8217;s fan-driven revenue streams in the region and promote regional goodwill.
Notably, President Donald Trump earlier this week indicated about &#8216;potential&#8217; trade deal with South Korea, besides India and Japan.
On Friday, China&#8217;s Commerce Ministry said that the country is <a href="https://www.benzinga.com/25/05/45160145/china-says-door-is-open-for-talks-while-it-is-assessing-us-trade-proposal-but-warns-coercion-and-extortion-wont-work">assessing </a>a U.S. offer to discuss the crippling 145% tariffs imposed by Trump. This move towards de-escalation comes amid China&#8217;s <a href="https://www.benzinga.com/news/global/25/04/45094345/as-chinas-manufacturing-contracts-beijing-releases-defiant-video-calling-us-a-paper-tiger-and-vows-to-never-kneel-to-trumps-trade-war">manufacturing activity</a> contracting for the first time in three months.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/04/45074825/jeff-bezos-says-an-employee-looked-at-me-like-i-was-the-stupidest-person-theyd-ever-seen-then-offered-a-simp" target="_blank" rel="noreferrer noopener">Jeff Bezos Says An Employee &#8216;Looked At Me Like I Was the Stupidest Person They&#8217;d Ever Seen&#8217; — Then Offered A Simple Idea That Changed Amazon</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

China Turns To K-Pop For First Time Since 2016 To Spur Consumption, Strengthen Ties With South Korea Amid US Trade Tensions

Barrington Research analyst Alexander Paris maintains Perdoceo Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) with a Outperform and raises the price target from $35 to $38.

PRDO

Barrington Research Maintains Outperform on Perdoceo Education, Raises Price Target to $38

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer recommended buying BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>). &#8220;Long term, I think it's going to be a <a href="https://www.benzinga.com/quote/BLK/earnings">great position,&#8221; he added.</a>
Lending support to his choice, BlackRock reported a first-quarter adjusted EPS beat in April and announced that assets under management reached historic highs.
&#8220;We're not recommending stocks right now that are losing a lot of money because we think this could be a dicey environment,&#8221; Cramer said when asked about Tempus AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>).
On the earnings front, Tempus AI will report financial results for the first quarter on Tuesday, May 6.
Cramer said no to Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>), adding that the company reported a &#8220;bad couple of quarters.&#8221;
Supporting his view, Citigroup analyst Vikram Bagri, on April 17, downgraded the rating for Sunrun from Buy to Neutral and announced a $7 price target.
The Mad Money host said he likes ExlService Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXLS#NASDAQ">EXLS</a>), adding that it is &#8220;one of the fintech stocks that's been proving to be very solid.&#8221;
Lending support to his choice, ExlService Holdings posted better-than-expected earnings results for the first quarter on April 29.
Cramer said he wants to buy Union Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) right here as he likes this level.
On the earnings front, Union Pacific, on April 24, reported quarterly operating revenue of $6.027 billion, flat year-over-year, missing the consensus of $6.08 billion
Price Action:
<ul>
<li>BlackRock shares gained 0.2% to settle at $916.14 on Thursday.</li>
<li>Tempus AI shares rose 0.4% to close at $51.85 during the session.</li>
<li>Sunrun shares gained 4.4% to settle at $7.19 on Thursday.</li>
<li>ExlService shares fell 4.5% to close at $46.31.</li>
<li>Union Pacific shares fell 0.7% to settle at $214.08 on Thursday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45134238/top-2-real-estate-stocks-that-may-keep-you-up-at-night-in-may">Top 2 Real Estate Stocks That May Keep You Up At Night In May</a></li>
</ul>
Image: Shutterstock

EXLS

Jim Cramer: Sunrun Had 'Bad Couple Of Quarters,' ExlService Holdings Is 'Solid'

BGM Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGM#NASDAQ">BGM</a>) (the "Company" or "BGM") , a leading AI technology company, today announced it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million).
Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ("Shuda Technology") and New Media Star Technology (Shenzhen) Co., Ltd ( "New Media Star"). The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions.
The acquisition expands the Company's AI application portfolio and further integrates existing market resources from its AI insurance and AI mobility businesses, further solidifying the Company's position in the AI industry.
 &nbsp;

BGM Group To Acquire HM Management In All-Stock Transaction Valued At About US$41.7M

WIIM

FIVE

Five Below shares are trading higher after the company raised its Q1 outlook.

Chardan Capital analyst Geulah Livshits maintains Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) with a Buy and maintains $12 price target.

SNTI

Chardan Capital Maintains Buy on Senti Biosciences, Maintains $12 Price Target

Five Below Raises Q1 Adj EPS Guidance from $0.50-$0.61 to $0.82-$0.84; Raises  Revenue Guidance From $905M-$925M To ~$967M

Press Releases

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Sight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

General

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

Health Care

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

Management

Sight Sciences Appoints Gary Burbach to its Board of Directors

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

BWXT

SGHT

Accuray

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

BrainsWay Ltd. - American Depositary Shares

BrainsWay

CVRx

Alpha Tau Medical

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Sight Sciences

Sight Sciences (SGHT) オプション

Sight Sciences (NASDAQ:SGHT) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル